{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T15:49:02Z","timestamp":1786636142941,"version":"build-2736575974"},"reference-count":11,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Pharmacol"],"published-print":{"date-parts":[[2020]]},"DOI":"10.4103\/ijp.ijp_655_18","type":"journal-article","created":{"date-parts":[[2020,6,2]],"date-time":"2020-06-02T06:12:15Z","timestamp":1591078335000},"page":"134","source":"Crossref","is-referenced-by-count":8,"title":["The effect of long-term valproic acid treatment in the level of total cholesterol among adult"],"prefix":"10.4103","volume":"52","author":[{"given":"Santoso","family":"Jaeri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kurnia","family":"Kusumastuti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0253-7613.285733-1","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1097\/FPC.0b013e32835ea0b2","article-title":"Valproic acid pathway: Pharmacokinetics and pharmacodynamics","author":"Ghodke-Puranik","year":"2013","journal-title":"Pharmacogenet Genomics"},{"key":"key-10.4103\/0253-7613.285733-2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.eplepsyres.2013.08.016","article-title":"Metabolic and endocrine effects of valproic acid chronic treatment","author":"Belcastro","year":"2013","journal-title":"Epilepsy Res"},{"key":"key-10.4103\/0253-7613.285733-3","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.pediatrneurol.2009.06.003","article-title":"Metabolic alterations during valproic acid treatment: A prospective study","author":"Abaci","year":"2009","journal-title":"Pediatr Neurol"},{"key":"key-10.4103\/0253-7613.285733-4","doi-asserted-by":"crossref","first-page":"e001974","DOI":"10.1161\/JAHA.112.001974","article-title":"Relation between serum total cholesterol level and cardiovascular disease stratified by sex and age group: A pooled analysis of 65 594 individuals from 10 cohort studies in Japan","author":"Nagasawa","year":"2012","journal-title":"J Am Heart Assoc"},{"key":"key-10.4103\/0253-7613.285733-5","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1111\/j.1528-1157.1984.tb03480.x","article-title":"Heart disease mortality and morbidity in patients with epilepsy","author":"Annegers","year":"1984","journal-title":"Epilepsia"},{"key":"key-10.4103\/0253-7613.285733-6","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.seizure.2018.06.003","article-title":"Biochemical derangements related to metabolic syndrome in epileptic patients on treatment with valproic acid","author":"Nisha","year":"2018","journal-title":"Seizure"},{"key":"key-10.4103\/0253-7613.285733-7","first-page":"153","article-title":"Effects of treatment with antiepileptic drugs on serum lipid profile in epileptic children","author":"Kantoush","year":"1998","journal-title":"Alex J Pediatr","ISSN":"https:\/\/id.crossref.org\/issn\/1687-9945","issn-type":"print"},{"key":"key-10.4103\/0253-7613.285733-8","first-page":"1","article-title":"Hypoglycemic, antilipidemic and antioxidant effects of valproic acid in Alloxan-induced diabetic rats","author":"Akindele","year":"2015","journal-title":"Eur J Pharmacol"},{"key":"key-10.4103\/0253-7613.285733-9","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.atherosclerosis.2017.09.034","article-title":"4-phenylbutyrate and valproate treatment attenuates the progression of atherosclerosis and stabilizes existing plaques","author":"Huang","year":"2017","journal-title":"Atherosclerosis"},{"key":"key-10.4103\/0253-7613.285733-10","doi-asserted-by":"crossref","first-page":"3304","DOI":"10.1016\/j.ajpath.2015.08.006","article-title":"Valproic acid limits pancreatic recovery after pancreatitis by inhibiting histone deacetylases and preventing acinar redifferentiation programs","author":"Eisses","year":"2015","journal-title":"Am J Pathol"},{"key":"key-10.4103\/0253-7613.285733-11","doi-asserted-by":"crossref","first-page":"6373","DOI":"10.1128\/MCB.00413-08","article-title":"Histone deacetylase inhibitors modify pancreatic cell fate determination and amplify endocrine progenitors","author":"Haumaitre","year":"2008","journal-title":"Mol Cell Biol"}],"container-title":["Indian Journal of Pharmacology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T14:54:12Z","timestamp":1786632852000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijp.IJP_655_18"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":11,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020]]}},"alternative-id":["285733"],"URL":"https:\/\/doi.org\/10.4103\/ijp.ijp_655_18","relation":{},"ISSN":["0253-7613"],"issn-type":[{"value":"0253-7613","type":"print"}],"subject":[],"published":{"date-parts":[[2020]]}}}